XML 56 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Segmentation of key figures (Details 8) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Disclosure of operating segments [line items]        
Net sales to third parties from continuing operations $ 11,347 $ 11,764 $ 23,630 $ 22,870
Change over period [member]        
Disclosure of operating segments [line items]        
Net sales, change in % (4.00%)   3.00%  
Net sales, change in %, cc (1.00%)   6.00%  
Sandoz [member]        
Disclosure of operating segments [line items]        
Net sales to third parties from continuing operations $ 2,159 2,438 $ 4,687 4,764
Sandoz [member] | Change over period [member]        
Disclosure of operating segments [line items]        
Net sales, change in % (11.00%)   (2.00%)  
Net sales, change in %, cc (9.00%)   1.00%  
Sandoz [member] | Retail Generics [member]        
Disclosure of operating segments [line items]        
Net sales to third parties from continuing operations $ 1,576 1,903 $ 3,545 3,753
Sandoz [member] | Retail Generics [member] | Change over period [member]        
Disclosure of operating segments [line items]        
Net sales, change in % (17.00%)   (6.00%)  
Net sales, change in %, cc (14.00%)   (3.00%)  
Sandoz [member] | Biopharmaceuticals [member]        
Disclosure of operating segments [line items]        
Net sales to third parties from continuing operations $ 466 401 $ 916 752
Sandoz [member] | Biopharmaceuticals [member] | Change over period [member]        
Disclosure of operating segments [line items]        
Net sales, change in % 16.00%   22.00%  
Net sales, change in %, cc 19.00%   25.00%  
Sandoz [member] | Anti Infectives [member]        
Disclosure of operating segments [line items]        
Net sales to third parties from continuing operations $ 117 134 $ 226 259
Sandoz [member] | Anti Infectives [member] | Change over period [member]        
Disclosure of operating segments [line items]        
Net sales, change in % (13.00%)   (13.00%)  
Net sales, change in %, cc (12.00%)   (11.00%)  
Sandoz [member] | Anti Infectives [member] | Anti Infectives sold under Sandoz name [member]        
Disclosure of operating segments [line items]        
Net sales to third parties from continuing operations $ 134 $ 186 $ 356 $ 390